Disposition of 137 shares by Titus Ball of BeiGene at 189.9413 subject to Rule 16b-3
BGNEDelisted Stock | USD 184.71 0.71 0.39% |
About 56% of BeiGene's investor base is looking to short. The analysis of current outlook of investing in BeiGene suggests that many traders are alarmed regarding BeiGene's prospects. The current market sentiment, together with BeiGene's historical and current headlines, can help investors time the market. In addition, many technical investors use BeiGene stock news signals to limit their universe of possible portfolio assets.
BeiGene |
Filed transaction by BeiGene Officer: Principal Accounting Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at simplywall.st
BeiGene Fundamental Analysis
We analyze BeiGene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BeiGene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BeiGene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Asset
Total Asset Comparative Analysis
BeiGene is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
BeiGene Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BeiGene stock to make a market-neutral strategy. Peer analysis of BeiGene could also be used in its relative valuation, which is a method of valuing BeiGene by comparing valuation metrics with similar companies.
Peers
BeiGene Related Equities
BPMC | Blueprint Medicines | 5.87 | ||||
AKRO | Akero Therapeutics | 4.71 | ||||
LEGN | Legend Biotech | 3.91 | ||||
ARWR | Arrowhead Pharmaceuticals | 2.84 | ||||
KRYS | Krystal Biotech | 2.47 | ||||
APLS | Apellis Pharmaceuticals | 0.71 | ||||
BMRN | Biomarin Pharmaceutical | 0.46 | ||||
IMVT | Immunovant | 0.25 | ||||
TVTX | Travere Therapeutics | 0.54 | ||||
INCY | Incyte | 0.75 | ||||
IONS | Ionis Pharmaceuticals | 2.63 | ||||
ASND | Ascendis Pharma | 2.65 | ||||
IMAB | I Mab | 2.73 | ||||
PCVX | Vaxcyte | 2.88 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in BeiGene Stock
If you are still planning to invest in BeiGene check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BeiGene's history and understand the potential risks before investing.
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Stocks Directory Find actively traded stocks across global markets | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |